Rock Health and ZS Associates created a handy chart to show pharma companies if they are "fast followers" or "first movers" in digital therapeutics (if you're not on the chart presumably your firm is a laggard -Ed.).
Eddie Martucci, CEO & Co-founder of digital therapeutic company Akili Interactive summed it up well:
Today, patients have a limitedâ€”if anyâ€”relationship with the companies that make and distribute their medicine. The benefit of digital health is we have a chance, through data, to deeply engage with our patientsâ€”to listen to them, and take cues from them. This is a philosophy that almost cuts against what the current medication industry has been able to do. But digital is a new modality, and there is no well-oiled machine on how to prescribe and follow-up with a software-based medication.